[go: up one dir, main page]

NO20021407D0 - Biphenyl derivatives used as NHE-3 inhibitors - Google Patents

Biphenyl derivatives used as NHE-3 inhibitors

Info

Publication number
NO20021407D0
NO20021407D0 NO20021407A NO20021407A NO20021407D0 NO 20021407 D0 NO20021407 D0 NO 20021407D0 NO 20021407 A NO20021407 A NO 20021407A NO 20021407 A NO20021407 A NO 20021407A NO 20021407 D0 NO20021407 D0 NO 20021407D0
Authority
NO
Norway
Prior art keywords
nhe
inhibitors
derivatives used
biphenyl derivatives
biphenyl
Prior art date
Application number
NO20021407A
Other languages
Norwegian (no)
Other versions
NO20021407L (en
Inventor
Dieter Dorsch
Peter Raddatz
Norbert Beier
Claudia Wilm
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20021407D0 publication Critical patent/NO20021407D0/en
Publication of NO20021407L publication Critical patent/NO20021407L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021407A 1999-09-22 2002-03-21 Biphenyl derivatives used as NHE-3 inhibitors NO20021407L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19945302A DE19945302A1 (en) 1999-09-22 1999-09-22 Biphenyl derivatives as NHE-3 inhibitors
PCT/EP2000/008616 WO2001021582A1 (en) 1999-09-22 2000-09-04 Biphenyl derivatives used as nhe-3 inhibitors

Publications (2)

Publication Number Publication Date
NO20021407D0 true NO20021407D0 (en) 2002-03-21
NO20021407L NO20021407L (en) 2002-03-21

Family

ID=7922831

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021407A NO20021407L (en) 1999-09-22 2002-03-21 Biphenyl derivatives used as NHE-3 inhibitors

Country Status (16)

Country Link
EP (1) EP1214291A1 (en)
JP (1) JP2004500338A (en)
KR (1) KR20020033818A (en)
CN (1) CN1555356A (en)
AU (1) AU7649700A (en)
BR (1) BR0014199A (en)
CA (1) CA2387529A1 (en)
CZ (1) CZ2002815A3 (en)
DE (1) DE19945302A1 (en)
HU (1) HUP0202891A3 (en)
MX (1) MXPA02003087A (en)
NO (1) NO20021407L (en)
PL (1) PL355097A1 (en)
SK (1) SK3342002A3 (en)
WO (1) WO2001021582A1 (en)
ZA (1) ZA200203095B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10163239A1 (en) * 2001-12-21 2003-07-10 Aventis Pharma Gmbh Substituted imidazolidines, process for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
US7049333B2 (en) 2002-06-04 2006-05-23 Sanofi-Aventis Deutschland Gmbh Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds
DE10304374A1 (en) 2003-02-04 2004-08-05 Aventis Pharma Deutschland Gmbh Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic agent and medicament containing them
US20050054705A1 (en) 2003-02-04 2005-03-10 Aventis Pharma Deutschland Gmbh N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE10341240A1 (en) 2003-09-08 2005-04-07 Aventis Pharma Deutschland Gmbh Substituted thienoimidazoles, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
DE102005001411A1 (en) 2005-01-12 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them
ATE479679T1 (en) 2007-06-28 2010-09-15 Sanofi Aventis Us Llc METHOD FOR PRODUCING N-(2-CHLORINE-4-METHYL-3-THIENYL)-1H-BENZIMIDAZOLE-2-AMINE HYDROCHLORIDE AND INTERMEDIATE PRODUCTS THEREFOR
WO2010025856A1 (en) 2008-09-02 2010-03-11 Sanofi-Aventis Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
EP3351248B1 (en) 2008-12-31 2021-06-09 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ES2575478T3 (en) 2011-03-15 2016-06-28 Astellas Pharma Inc. Guanidine compound
CN103012200B (en) * 2011-09-20 2014-12-17 北京大学 Compound with β-secretase inhibitory function and its preparation method and application
CA2880338A1 (en) 2012-08-21 2014-02-27 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
KR102287207B1 (en) 2013-04-12 2021-08-09 알데릭스, 인코포레이티드 Nhe3-binding compounds and methods for inhibiting phosphate transport
MX375386B (en) 2014-07-25 2025-03-06 Taisho Pharmaceutical Co Ltd HETEROARYL-SUBSTITUTED PHENYLTETRAHYDROISOQUINOLINE COMPOUND.
CN110267944B (en) 2017-01-09 2024-03-08 阿德利克斯股份有限公司 Compounds useful in treating gastrointestinal disorders
JP2020505333A (en) 2017-01-09 2020-02-20 アルデリックス， インコーポレイテッド Inhibitors of NHE-mediated antiport
CN118440135A (en) 2017-08-04 2024-08-06 阿德利克斯股份有限公司 Glycyrrhetinic acid derivatives for the treatment of hyperkalemia
CN114008065B (en) 2019-02-07 2025-03-11 阿德利克斯股份有限公司 Glycyrrhetinic acid derivatives for the treatment of hyperkalemia
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19548812A1 (en) * 1995-12-27 1997-07-03 Hoechst Ag Use of inhibitors of the cellular Na · + · / H · + · exchanger (NHE) for the manufacture of a medicament for respiratory stimulation
DE19622222A1 (en) * 1996-06-03 1997-12-04 Hoechst Ag Use of sodium=proton exchange inhibitor
DE19737224A1 (en) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmaceutical preparation for cardiovascular treatment
DE19819548A1 (en) * 1998-04-30 1999-11-04 Merck Patent Gmbh Biphenyl derivatives

Also Published As

Publication number Publication date
AU7649700A (en) 2001-04-24
SK3342002A3 (en) 2002-07-02
KR20020033818A (en) 2002-05-07
DE19945302A1 (en) 2001-03-29
MXPA02003087A (en) 2003-08-20
BR0014199A (en) 2002-05-21
CN1555356A (en) 2004-12-15
EP1214291A1 (en) 2002-06-19
HUP0202891A2 (en) 2003-02-28
PL355097A1 (en) 2004-03-22
NO20021407L (en) 2002-03-21
CA2387529A1 (en) 2001-03-29
JP2004500338A (en) 2004-01-08
HUP0202891A3 (en) 2003-11-28
ZA200203095B (en) 2003-09-23
CZ2002815A3 (en) 2002-08-14
WO2001021582A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
NO20021407L (en) Biphenyl derivatives used as NHE-3 inhibitors
DK1244647T3 (en) Quinzoline derivatives as VIGF inhibitors
DK2253620T3 (en) SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN-TYROSINKINASE INHIBITORS
NO20021239L (en) Pteridinones as kinase inhibitors
NO20024997D0 (en) 2-guanidino-4-arylquinazolines as NHE-3 inhibitors
NO20030055D0 (en) Colchinol derivatives as angiogenesis inhibitors
NO20023828L (en) Pyrimidin-4-one derivatives as LDL-PLA2 inhibitors
NO20030867L (en) Hydroxam derivatives useful as deacetylase inhibitors
NO20014483L (en) Amine derivatives as protease inhibitors
NO992725L (en) 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors
NO20015065D0 (en) Pyrazolobenzodiazepines as CDK2 inhibitors
NO20014412L (en) Compounds useful as anti-inflammatory agents
NO20031006D0 (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibiting cell proliferation
NO20032994D0 (en) VLA-4 inhibitors
NO20033618L (en) Phthalayinone-piperidino derivatives as PDE-4 inhibitors
DK1097127T3 (en) Diacylhydrazine derivatives as integrin inhibitors
NO20022558D0 (en) 4-Carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as CETP inhibitor
NO20016201D0 (en) Tienopyrimidines as phosphodiesterase inhibitors
NO20021959L (en) Tetrahydrotiopyranephthalazinone derivatives as PDE4 inhibitors
NO991994D0 (en) Substituted 4-biphenyl-4-hydroxy acid derivatives as matrix metalloprotease inhibitors
NO20023001D0 (en) Substituted piperazine derivatives as MTP inhibitors
DE60009260D1 (en) THIOPYRANDERIVATE AS MMP INHIBITORS
NO20011654D0 (en) Benzamide derivatives as thrombin inhibitors
DK1077945T3 (en) Isoquinolines as urokinase inhibitors
NO20020592D0 (en) Fluorine derivatives as integrin inhibitors